Clinical Trials Logo

Unconsciousness clinical trials

View clinical trials related to Unconsciousness.

Filter by:

NCT ID: NCT03290859 Completed - Hypoxemia Clinical Trials

Race-Specific Propofol Titration to Effect for Procedural Sedation

Start date: January 5, 2018
Phase:
Study type: Observational

Prospectively evaluate newly established guidelines and make clinicians aware of inter-racial difference in propofol sensitivity.

NCT ID: NCT03284307 Completed - Unconsciousness Clinical Trials

UNderstanding CONSciousness Connectedness and Intraoperative Unresponsiveness Study

UN-CONSCIOUS
Start date: August 10, 2017
Phase: Phase 4
Study type: Interventional

This study will be a single-site, controlled, unblinded study at the University of Wisconsin to examine changes in the electroencephalogram during anesthesia and waking.

NCT ID: NCT03240055 Completed - Clinical trials for Dose-Response Relationship, Drug

The Effects of Spinal Anesthesia on ED50 and BIS50 of Etomidate for the Loss of Consciousness

LOC
Start date: June 1, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the effect of spinal anesthesia on ED50 and BIS50 of etomidate for the loss of consciousness (LOC) by using up-and-down method.The hypothesis was that spinal anesthesia could significantly reduce the etomidate bolus dose for the LOC and could also achieve hemodynamic stability during anesthesia induction.

NCT ID: NCT03140982 Completed - Clinical trials for Anesthesia; Functional

Is Anesthetic Loss of Consciousness a Top Down or Bottom up Phenomenon. What Does the Neurologic Examination Say?.

Top&Bottom
Start date: June 1, 2016
Phase: N/A
Study type: Interventional

Using very slow or fast propofol intravenous injection, monitored using standard American Society of Anesthesiology (ASA) standard and SEDLine EEG (Med Tech), the patient was evaluate by a neurologist every 30 sec using the FOUR coma scale.

NCT ID: NCT02874027 Recruiting - Clinical trials for Traumatic Brain Injury With Brief Loss of Consciousness

The Clinical Research on the Relationship Between Depression and Gut Microbiota in TBI Patients

Start date: August 2016
Phase: N/A
Study type: Observational

Microbiome studies may be highlighted as crucial in the development of depression for TBI patients. The microbiota-gut-brain connection may further provide an opportunity for microbiota manipulation to treat the TBI patients with depression.This study is to investigate whether exist the relationship between depression and circadian rhythm of patients with TBI or not and focus the study on the potential of the host-microbiota interaction in regulating depression.

NCT ID: NCT02858544 Completed - Brain Injuries Clinical Trials

Concussion in Motor Vehicle Accidents: The Concussion Identification Index

CIDI
Start date: November 2013
Phase: N/A
Study type: Observational

The primary goal of this study is to provide clinicians with a brief, patient self-administer instrument yielding a single composite score that reliably correlates with objective findings on standardized neurocognitive assessment for concussion.

NCT ID: NCT02849028 Recruiting - Clinical trials for Traumatic Brain Injury

The Clinical Research on the Relationship Between Circadian Rhythm and Gut Microbiota in TBI Patients

Start date: July 2016
Phase: N/A
Study type: Observational

Microbiome studies may be highlighted as crucial in the development of sleep disorder for TBI patients. The microbiota-gut-brain connection may further provide an opportunity for microbiota manipulation to treat the TBI patients with sleep disorders.This study is to investigate whether exist the relationship between sleep disorder and circadian rhythm of patients with TBI or not and focus the study on the potential of the host-microbiota interaction in regulating sleep disorder.

NCT ID: NCT02831101 Completed - Clinical trials for Loss of Consciousness

Sufentanil Bispectral Index Elderly

Start date: February 2012
Phase: N/A
Study type: Interventional

We compared BIS values during propofol stepwise induction with or without concomitant sufentanil in patients ≥ 65 years .

NCT ID: NCT02818387 Recruiting - Anesthesia Clinical Trials

Remifentanil and Midazolam on Propofol for Loss of Consciousness in Elderly Patients

Start date: October 2015
Phase: N/A
Study type: Interventional

Propofol is a well-known induction agent which can provide sound and quick hypnosis with anti-emetic effects. However, dose dependent hypotension or bradycardia have reported while using this agent. Propofol in combination with remifentanil or midazolam can result in synergistic or additive effect in elderly patients. There are not many studies which provide minimum dose of propofol to induce hypnosis in combination with these agents and advantage of the combination. The elderly patients (over 65 years old) who are scheduled to undergo general anesthesia are enrolled in this study. 120 patients will be randomly allocated to 3 groups(P, PR, PMR). Sample size have been decided due to the previous studies which have mentioned 40 participants as a adequate sample size for this biased coin design - up and down study. After receiving informed consent, patients will be participated in this study. No premedication will be given to the patients before induction. The patients in group P will receive general anesthesia only with propofol and group PR and PMR will receive 0.125 mcg/kg/min remifentanil infusion for 5 min prior to propofol administration. The patients in group PMR will receive 0.015 mg/kg bolus dose of midazolam 1 min after the start of the remifentanil infusion. Initial propofol dose will be 0.5 mg/kg in each group and the dose will be changed by the result of prior study participant. 'Success' of this study will be defined as loss of both verbal response and eyelash reflex in 3 min after propofol administration. When 'success', the next patient will receive the same dose(in 18/19 probability) or 0.125 mg/kg lower dose(in 1/19 probability) of propofol. When 'failure', the next patient will receive 0.125 mg/kg higher dose of propofol at induction period.

NCT ID: NCT02783846 Completed - Clinical trials for Loss of Consciousness

The Effects of Different Doses of Dexmedetomidine on Propofol Requirement for Loss of Consciousness Undergoing Bispectral Index: a Double-blinded, Placebo-controlled Trial

Start date: June 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the effects of different dexmedetomidine on the propofol requirement for loss of consciousness undergoing bispectral index.